Indications
Hypertension. Angina pectoris and vasospastic (Prinzmetal’s)
angina. Supraventricular tachyarrhythmias and
rapid ventricular rates in atrial flutter or fibrillation.
Action
Inhibits transport of calcium into myocardial and vascular
smooth muscle cells, resulting in inhibition of excitation-
contraction coupling and subsequent contraction.
Therapeutic Effects: Systemic vasodilation
resulting in decreased BP. Coronary vasodilation resulting
in decreased frequency and severity of attacks of angina.
Reduction of ventricular rate in atrial fibrillation
or flutter.
Pharmacokinetics
Absorption: Well absorbed, but rapidly metabolized
after oral administration.
Distribution: Unknown.
Protein Binding: 70–80%.
Metabolism and Excretion: Mostly metabolized
by the liver (CYP3A4 enzyme system).
Half-life: 3.5–9 hr.
TIME/ACTION PROFILE
ROUTE ONSET PEAK DURATION
PO 30 min 2–3 hr 6–8 hr
PO–CD, LA,
XT
unknown 14 days† up to 24 hr
IV 2–5 min 2–4 hr unknown
†Maximum antihypertensive effect with chronic therapy.
Contraindications/Precautions
Contraindicated in: Hypersensitivity; Sick sinus
syndrome; 2nd- or 3rd-degree AV block (unless an artificial
pacemaker is in place); Systolic BP 90 mm Hg;
Recent MI or pulmonary congestion; Concurrent use of
rifampin.
Use Cautiously in: Severe hepatic impairment (p
dose recommended); Geri:pdose; slower IV infusion
rate recommended;qrisk of hypotension; consider
age-related decrease in body mass,phepatic/renal/
cardiac function, concurrent drug therapy and other
disease states); Severe renal impairment; Serious ventricular
arrhythmias or HF; OB, Lactation, Pedi: Safety
not established.
Adverse Reactions/Side Effects
CNS: abnormal dreams, anxiety, confusion, dizziness,
drowsiness, headache, nervousness, psychiatric disturbances,
weakness. EENT: blurred vision, disturbed
equilibrium, epistaxis, tinnitus. Resp: cough, dyspnea.
CV: ARRHYTHMIAS, HF, peripheral edema, bradycardia,
chest pain, hypotension, palpitations, syncope, tachycardia.
GI:qliver enzymes, anorexia, constipation, diarrhea,
dry mouth, dysgeusia, dyspepsia, nausea, vomiting.
GU: dysuria, nocturia, polyuria, sexual
dysfunction, urinary frequency. Derm: STEVENS-JOHNSON
SYNDROME, dermatitis, erythema multiforme, flushing,
sweating, photosensitivity, pruritus/urticaria, rash.
Endo: gynecomastia, hyperglycemia. Hemat: anemia,
leukopenia, thrombocytopenia.Metab: weight
gain. MS: joint stiffness, muscle cramps. Neuro: paresthesia,
tremor. Misc: gingival hyperplasia.
Interactions
Drug-Drug:qhypotension may occur when used
with fentanyl, other antihypertensives, nitrates,
acute ingestion of alcohol, or quinidine. Antihypertensive
effects may bepby NSAIDs. Mayqdigoxin
levels. Mayqlevels of and risk of myopathy from simvastatin
and lovastatin. Concurrent use with beta
blockers, clonidine, digoxin, disopyramide, ivabradine,
or phenytoin may result in bradycardia,
conduction defects, or HF; avoid concurrent use with
ivabradine. Phenobarbital and phenytoin mayqmetabolism
andpeffectiveness. Maypmetabolism of and
qrisk of toxicity from cyclosporine, quinidine, or
carbamazepine. Cimetidine and ranitidineqlevels
and effects. Mayqorpthe effects of lithium or theophylline.
Drug-Food: Grapefruit juiceqlevels and effect.
Route/Dosage
PO (Adults): 30–120 mg 3–4 times daily or 180–
240 mg once daily as CD or XR capsules or LA tablets
(up to 360 mg/day); Concurrent simvastatin therapy—
Diltiazem dose should not exceed 240 mg/day
and simvastatin dose should not exceed 10 mg/day.
IV (Adults): 0.25 mg/kg; may repeat in 15 min with a
dose of 0.35 mg/kg. May follow with continuous infusion
at 10 mg/hr (range 5–15 mg/hr) for up to 24 hr.
Availability (generic available)
Tablets: 30 mg, 60 mg, 90 mg, 120 mg. Cost: Generic—
30 mg $10.44/100, 60 mg $22.25/100, 90 mg
$26.89/100. Extended-release capsules (Cardizem
CD, Tiazac, Cartia XT, Taztia XT): 120 mg,
180 mg, 240 mg, 300 mg, 360 mg, 420 mg. Cost: Generic—
180 mg $58.19/100, 240 mg $63.54/100, 420
mg $171.49/100. Extended-release tablets (Cardizem
LA): 120 mg, 180 mg, 240 mg, 300 mg, 360 mg,
420 mg. Solution for injection: 5 mg/mL.
No comments:
Post a Comment